Rui Li

17.8k total citations · 2 hit papers
436 papers, 13.0k citations indexed

About

Rui Li is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rui Li has authored 436 papers receiving a total of 13.0k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Molecular Biology, 99 papers in Cancer Research and 92 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rui Li's work include Cancer-related molecular mechanisms research (61 papers), MicroRNA in disease regulation (46 papers) and RNA modifications and cancer (41 papers). Rui Li is often cited by papers focused on Cancer-related molecular mechanisms research (61 papers), MicroRNA in disease regulation (46 papers) and RNA modifications and cancer (41 papers). Rui Li collaborates with scholars based in China, United States and Sweden. Rui Li's co-authors include Howard Y. Chang, Robert B. West, Pedram Argani, Hugo M. Horlings, Tiffany Hung, Ke Wang, Yulei Wang, David J. Wong, Saraswati Sukumar and Jeewon Kim and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Rui Li

405 papers receiving 12.9k citations

Hit Papers

Long non-coding RNA HOTAIR reprograms chromatin state to ... 2010 2026 2015 2020 2010 2024 1000 2.0k 3.0k 4.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rui Li China 50 7.7k 6.0k 1.8k 1.1k 934 436 13.0k
Fang Liu China 60 8.6k 1.1× 3.4k 0.6× 623 0.3× 1.4k 1.2× 720 0.8× 386 12.9k
Jianhua Zhang China 59 6.7k 0.9× 2.7k 0.4× 1.2k 0.6× 2.0k 1.7× 1.9k 2.0× 396 13.0k
Ying Wang China 60 6.8k 0.9× 2.3k 0.4× 2.2k 1.2× 1.3k 1.1× 911 1.0× 658 14.8k
Li Wang China 61 9.5k 1.2× 5.0k 0.8× 1.1k 0.6× 2.2k 1.9× 703 0.8× 717 15.3k
Qian Li China 63 6.3k 0.8× 1.8k 0.3× 1.9k 1.0× 1.0k 0.9× 675 0.7× 461 13.9k
Yongyong Shi China 46 5.2k 0.7× 2.4k 0.4× 987 0.5× 2.0k 1.8× 824 0.9× 362 11.3k
Qian Zhang China 51 6.2k 0.8× 3.6k 0.6× 1.1k 0.6× 1.8k 1.6× 659 0.7× 472 11.4k
Marina Ziche Italy 59 7.1k 0.9× 2.4k 0.4× 944 0.5× 2.3k 2.0× 1.5k 1.6× 212 13.7k
Ali Mobasheri United Kingdom 73 7.1k 0.9× 2.2k 0.4× 758 0.4× 1.4k 1.2× 3.0k 3.2× 394 19.5k
Chih‐Hsin Tang Taiwan 64 7.8k 1.0× 3.3k 0.6× 1.2k 0.7× 3.5k 3.1× 1.0k 1.1× 464 15.8k

Countries citing papers authored by Rui Li

Since Specialization
Citations

This map shows the geographic impact of Rui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Li more than expected).

Fields of papers citing papers by Rui Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Li. The network helps show where Rui Li may publish in the future.

Co-authorship network of co-authors of Rui Li

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Li. A scholar is included among the top collaborators of Rui Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Li. Rui Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meng, Meiyao, Shuang Liu, Yinzhao Zhong, et al.. (2025). Zinc finger protein ZNF638 in brown fat deteriorates type 1 diabetes via retinol binding protein 4. Science Bulletin. 71(3). 505–509.
2.
Liu, Jin, et al.. (2025). Peripheral Blood NMLR Can Predict 5-Year All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease. International Journal of COPD. Volume 20. 95–105.
3.
Li, Rui, Yani He, & Kehong Chen. (2025). Cognitive impairment in hemodialysis needs sufficient attention. 3(1). 19–22.
4.
Sun, Weiyi, et al.. (2025). Exploring symptom clusters and core symptoms during the vulnerable phase in patients with chronic heart failure: a network-based analysis. European Journal of Cardiovascular Nursing. 24(2). 279–287. 2 indexed citations
6.
Song, Bingbing, Zhuo Wang, Kit‐Leong Cheong, et al.. (2024). Ceramides from sea red rice bran ameliorate oxidative stress and lifespan in Caenorhabditis elegans by activating the p38/MAPK signaling pathway and regulating the gut microbiota. Journal of Functional Foods. 116. 106205–106205. 2 indexed citations
7.
Guo, Xin, et al.. (2024). Association between viral infection and bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis. European Journal of Pediatrics. 183(7). 2965–2981. 1 indexed citations
8.
Li, Rui, et al.. (2024). Estimating Coronary Sinus Oxygen Saturation from Pulmonary Artery Oxygen Saturation. Medicina. 60(11). 1882–1882.
9.
Wei, Xiang, et al.. (2023). Preoperative Immature Neutrophils Predict Clinical Outcomes in Patients with Uncomplicated Type-B Aortic Dissection After Thoracic Endovascular Aortic Repair. International Journal of General Medicine. Volume 16. 3637–3644. 2 indexed citations
10.
Nicola, Teodora, Rui Li, Sadis Matalon, et al.. (2023). Thyroid hormone modulates hyperoxic neonatal lung injury and mitochondrial function. JCI Insight. 8(8). 3 indexed citations
11.
Shi, Zhenduo, Lin Hao, Xiaoxiao Han, et al.. (2022). Targeting HNRNPU to overcome cisplatin resistance in bladder cancer. Molecular Cancer. 21(1). 37–37. 77 indexed citations
12.
Steyn, Frederik J., Rui Li, Tesfaye Wolde Tefera, et al.. (2020). Altered skeletal muscle glucose-fatty acid flux in amyotrophic lateral sclerosis. Brain Communications. 2(2). fcaa154–fcaa154. 39 indexed citations
13.
Huang, Rui, et al.. (2020). Pincer Nail Deformity: Clinical Characteristics, Causes, and Managements. BioMed Research International. 2020(1). 2939850–2939850. 9 indexed citations
14.
Feng, Guang, et al.. (2020). MiR‐140‐5p promotes osteogenic differentiation of mouse embryonic bone marrow mesenchymal stem cells and post‐fracture healing of mice. Cell Biochemistry and Function. 38(8). 1152–1160. 12 indexed citations
15.
Zhang, Miao, Rui Li, Hong Chen, Juan Zhou, & Ye Zhang. (2019). Application and efficacy evaluation of an NBASS-APS pain management model in postoperative analgesia for gastric cancer patients.. PubMed. 23(5). 1426–1431. 6 indexed citations
16.
Lu, Miao, Lin Yang, Rui Li, et al.. (2017). Disrupting Androgen Receptor Signaling Induces Snail-Mediated Epithelial–Mesenchymal Plasticity in Prostate Cancer. Cancer Research. 77(11). 3101–3112. 66 indexed citations
17.
Li, Rui, Zhongliang Hu, Shi‐Yong Sun, et al.. (2013). Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non–Small Cell Lung Cancer. Molecular Cancer Therapeutics. 12(10). 2200–2212. 129 indexed citations
18.
Li, Rui, Kamalesh Kumar Sharma, Kai‐Hsiung Chang, et al.. (2012). Abiraterone Inhibits 3β-Hydroxysteroid Dehydrogenase: A Rationale for Increasing Drug Exposure in Castration-Resistant Prostate Cancer. Clinical Cancer Research. 18(13). 3571–3579. 81 indexed citations
19.
Chang, Kai‐Hsiung, Rui Li, Mahboubeh Papari-Zareei, et al.. (2011). Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer. Proceedings of the National Academy of Sciences. 108(33). 13728–13733. 270 indexed citations
20.
Beck, Andrew H., Íñigo Espinosa, Badreddin Edris, et al.. (2009). The Macrophage Colony-Stimulating Factor 1 Response Signature in Breast Carcinoma. Clinical Cancer Research. 15(3). 778–787. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026